O'Connor, D., Moorman, A., Wade, R., Hancock, J., Tan, R., Bartram, J., . . . Samarasinghe, S. (2017). Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology.
Chicago Style (17th ed.) CitationO'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
ציטוט MLAO'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.